These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19126568)
1. RNA interference screening demystified. Lord CJ; Martin SA; Ashworth A J Clin Pathol; 2009 Mar; 62(3):195-200. PubMed ID: 19126568 [TBL] [Abstract][Full Text] [Related]
2. RNAi screening for the discovery of novel modulators of human disease. Seyhan AA; Rya TE Curr Pharm Biotechnol; 2010 Nov; 11(7):735-56. PubMed ID: 20420566 [TBL] [Abstract][Full Text] [Related]
4. RNAi screening: new approaches, understandings, and organisms. Mohr SE; Perrimon N Wiley Interdiscip Rev RNA; 2012; 3(2):145-58. PubMed ID: 21953743 [TBL] [Abstract][Full Text] [Related]
5. RNAi screening comes of age: improved techniques and complementary approaches. Mohr SE; Smith JA; Shamu CE; Neumüller RA; Perrimon N Nat Rev Mol Cell Biol; 2014 Sep; 15(9):591-600. PubMed ID: 25145850 [TBL] [Abstract][Full Text] [Related]
6. High-throughput screening using siRNA (RNAi) libraries. Chen M; Du Q; Zhang HY; Wang X; Liang Z Expert Rev Mol Diagn; 2007 May; 7(3):281-91. PubMed ID: 17489735 [TBL] [Abstract][Full Text] [Related]
7. RNAi screening for therapeutic targets in human malignancies. Micklem DR; Lorens JB Curr Pharm Biotechnol; 2007 Dec; 8(6):337-43. PubMed ID: 18289042 [TBL] [Abstract][Full Text] [Related]
8. Advances in genome-wide RNAi cellular screens: a case study using the Drosophila JAK/STAT pathway. Fisher KH; Wright VM; Taylor A; Zeidler MP; Brown S BMC Genomics; 2012 Sep; 13():506. PubMed ID: 23006893 [TBL] [Abstract][Full Text] [Related]
9. Transgene-Assisted Genetic Screen Identifies Long T; Meng F; Lu R J Virol; 2018 Sep; 92(17):. PubMed ID: 29950414 [TBL] [Abstract][Full Text] [Related]
10. Increasing the robustness and validity of RNAi screens. Haney SA Pharmacogenomics; 2007 Aug; 8(8):1037-49. PubMed ID: 17716236 [TBL] [Abstract][Full Text] [Related]
11. [RNA interference: biology and perspectives of application in biomedicine and biotechnology]. Vil'gel'm AE; Chumakov SP; Prasolov VS Mol Biol (Mosk); 2006; 40(3):387-403. PubMed ID: 16813159 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators. Mowa MB; Crowther C; Arbuthnot P Expert Opin Drug Deliv; 2010 Dec; 7(12):1373-85. PubMed ID: 21073358 [TBL] [Abstract][Full Text] [Related]
18. Using RNAi screening technologies to interrogate the extrinsic apoptosis pathway. Stephan JP Methods Enzymol; 2014; 544():129-60. PubMed ID: 24974289 [TBL] [Abstract][Full Text] [Related]
19. From genome to phenome--RNAi library screening and hit characterization using signaling pathway analysis. Chatterjee-Kishore M Curr Opin Drug Discov Devel; 2006 Mar; 9(2):231-9. PubMed ID: 16566293 [TBL] [Abstract][Full Text] [Related]
20. Strategies for silencing human disease using RNA interference. Kim DH; Rossi JJ Nat Rev Genet; 2007 Mar; 8(3):173-84. PubMed ID: 17304245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]